Clinical Research Directory

Browse clinical research sites, groups, and studies.

1 clinical study listed.

Healthy volunteers

Filters:

Hepatitis C,Chronic Children, Only

Tundra lists 1 Hepatitis C,Chronic Children, Only clinical trial. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07905989

Twelve Weeks Sofosbuvir/Daclatasvir in HCV Infected Children Aged 6-18 Years

Recently the era of direct-acting antiviral drugs for hepatitis C treatment has changed the world map of HCV. Results in adults are promising. FDA approved only two drugs in the pediatric age group 12 to 17 years. Younger children are still on the wait list for treatment. The current study aimed to study the efficacy and safety of combined sofosbuvir (SOF)/daclatasvir (DCV) in children with hepatitis C virus infection aged 6-18 years.

Gender: All

Ages: 6 Years - 18 Years

Updated: 2026-10-30

1 state

Hepatitis C,Chronic Children, Only